413 related articles for article (PubMed ID: 36675073)
41. Molecular genetics of radiographically defined de novo glioblastoma multiforme.
Tortosa A; Ino Y; Odell N; Swilley S; Sasaki H; Louis DN; Henson JW
Neuropathol Appl Neurobiol; 2000 Dec; 26(6):544-52. PubMed ID: 11123721
[TBL] [Abstract][Full Text] [Related]
42. Molecular profiling of an osseous metastasis in glioblastoma during checkpoint inhibition: potential mechanisms of immune escape.
Mohme M; Maire CL; Schliffke S; Joosse SA; Alawi M; Matschke J; Schüller U; Dierlamm J; Martens T; Pantel K; Riethdorf S; Lamszus K; Westphal M
Acta Neuropathol Commun; 2020 Mar; 8(1):28. PubMed ID: 32151286
[TBL] [Abstract][Full Text] [Related]
43. MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression.
Li W; Wu C; Yao Y; Dong B; Wei Z; Lv X; Zhang J; Xu Y
Neurosci Lett; 2014 Apr; 566():82-7. PubMed ID: 24582898
[TBL] [Abstract][Full Text] [Related]
44. CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component.
Xu G; Li JY
J Neurooncol; 2018 Feb; 136(3):445-452. PubMed ID: 29150788
[TBL] [Abstract][Full Text] [Related]
45. Cytokines play a key role in communication between mesenchymal stem cells and brain cancer cells.
Motaln H; Turnsek TL
Protein Pept Lett; 2015; 22(4):322-31. PubMed ID: 25642990
[TBL] [Abstract][Full Text] [Related]
46. Novel delivery methods bypassing the blood-brain and blood-tumor barriers.
Hendricks BK; Cohen-Gadol AA; Miller JC
Neurosurg Focus; 2015 Mar; 38(3):E10. PubMed ID: 25727219
[TBL] [Abstract][Full Text] [Related]
47. CNS macrophages and peripheral myeloid cells in brain tumours.
Glass R; Synowitz M
Acta Neuropathol; 2014 Sep; 128(3):347-62. PubMed ID: 24722970
[TBL] [Abstract][Full Text] [Related]
48. Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastoma.
Nepali K; Hsu TI; Hsieh CM; Lo WL; Lai MJ; Hsu KC; Lin TE; Chuang JY; Liou JP
Eur J Med Chem; 2021 May; 217():113338. PubMed ID: 33744690
[TBL] [Abstract][Full Text] [Related]
49. The Influence of Fluorine on the Disturbances of Homeostasis in the Central Nervous System.
Dec K; Łukomska A; Maciejewska D; Jakubczyk K; Baranowska-Bosiacka I; Chlubek D; Wąsik A; Gutowska I
Biol Trace Elem Res; 2017 Jun; 177(2):224-234. PubMed ID: 27787813
[TBL] [Abstract][Full Text] [Related]
50. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M
Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378
[TBL] [Abstract][Full Text] [Related]
51. FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells.
Li W; Fu X; Liu R; Wu C; Bai J; Xu Y; Zhao Y; Xu Y
Oncol Res; 2013; 21(2):111-20. PubMed ID: 24406047
[TBL] [Abstract][Full Text] [Related]
52. Analysis of dysregulated long non-coding RNA expressions in glioblastoma cells.
Balci T; Yilmaz Susluer S; Kayabasi C; Ozmen Yelken B; Biray Avci C; Gunduz C
Gene; 2016 Sep; 590(1):120-2. PubMed ID: 27306825
[TBL] [Abstract][Full Text] [Related]
53. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
[TBL] [Abstract][Full Text] [Related]
54. LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program.
Mao XG; Hütt-Cabezas M; Orr BA; Weingart M; Taylor I; Rajan AK; Odia Y; Kahlert U; Maciaczyk J; Nikkhah G; Eberhart CG; Raabe EH
Oncotarget; 2013 Jul; 4(7):1050-64. PubMed ID: 23846349
[TBL] [Abstract][Full Text] [Related]
55. Role of Circular RNA in Brain Tumor Development.
Ahmed SP; Castresana JS; Shahi MH
Cells; 2022 Jul; 11(14):. PubMed ID: 35883576
[TBL] [Abstract][Full Text] [Related]
56. Nanoparticles: Novel vehicles in treatment of Glioblastoma.
Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M
Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272
[TBL] [Abstract][Full Text] [Related]
57. Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells.
Lamballe F; Toscano S; Conti F; Arechederra M; Baeza N; Figarella-Branger D; Helmbacher F; Maina F
Oncotarget; 2016 Nov; 7(46):74747-74767. PubMed ID: 27732969
[TBL] [Abstract][Full Text] [Related]
58. A highly potent CDK4/6 inhibitor was rationally designed to overcome blood brain barrier in gliobastoma therapy.
Yin L; Li H; Liu W; Yao Z; Cheng Z; Zhang H; Zou H
Eur J Med Chem; 2018 Jan; 144():1-28. PubMed ID: 29247857
[TBL] [Abstract][Full Text] [Related]
59. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
Bai Y; Zhang QG; Wang XH
Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
[TBL] [Abstract][Full Text] [Related]
60. Role of extracellular vesicles in glioma progression.
Quezada C; Torres Á; Niechi I; Uribe D; Contreras-Duarte S; Toledo F; San Martín R; Gutiérrez J; Sobrevia L
Mol Aspects Med; 2018 Apr; 60():38-51. PubMed ID: 29222067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
